Robert Half reports Q2 results this evening with a positioning picture that has barely shifted since yesterday's preview: shorts remain heavily entrenched at 21.9% of free float, the stock has rallied 29% over the past month to $40.70, and the analyst community is split across a unusually wide range of targets.
The short interest story is one of gradual retreat, not capitulation. SI has edged down from roughly 27% of float in late June to 21.9% today — a nearly 20% decline in share terms over the month — but the absolute level keeps RHI among the most shorted names in the market, ranking in the 3rd percentile of the ORTEX universe on short score (73.4). The lending market gives shorts no reason to rush for the exit. Cost to borrow is negligible at 0.50%, and availability has loosened further to 178% — meaning nearly two shares remain available to borrow for every one currently shorted. That combination points to deliberate, tactical covering rather than a squeeze-driven exit. Options traders are modestly more defensive into the print, with the put/call ratio at 0.60, above its 20-day average of 0.46 by about 1.3 standard deviations — cautious, but not alarmed.
The analyst debate is where the real tension sits. Truist Securities raised its target to $50 yesterday while maintaining a Buy — an aggressive move made on the day of the print itself. Goldman Sachs, by contrast, holds a Sell rating with a $26 target, reaffirmed just last week after lifting it from $23. The stock is trading at $40.70. Goldman's target implies roughly 36% downside from here; Truist's implies 23% upside. The consensus mean target of around $32 sits well below the current price, meaning the stock has already run through what most of the Street considers fair value. Bulls point to the prospect of a recovery toward $7 billion in annual revenues with margins expanding to 13% — an EBITDA case above $900 million — while bears cite the 8% revenue decline last quarter, ongoing weakness in Contract Talent Solutions and Permanent Placement, and guidance pointing to further falls in Talent Solutions revenue of 10-14%.
Earnings history adds another layer of discomfort for longs. The last three prints each produced a negative day-one reaction: the most recent in late April saw the stock drop more than 13% on the day and nearly 10% over the following week. The two prior events saw smaller declines of 3-5% on the day. None of the recent prints produced a sustained rally in the days following. Against a backdrop where the stock has already gained 29% in a month and shorts are still carrying a material position, tonight's Q2 numbers are a direct test of whether management's recovery narrative — or Goldman's contraction thesis — is closer to reality.
See the live data behind this article on ORTEX.
Open RHI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
